The company said, “We expect that our cash, cash equivalents and short-term investments will be sufficient to fund our operations into 2026, based on our current operating plan.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AVTE:
- Aerovate Therapeutics Announces First Quarter Financial Results and Business Highlights
- AVTE Upcoming Earnings Report: What to Expect?
- Two new option listings on May 1st
- Aerovate Therapeutics management to meet virtually with Jefferies
- Fly Insider: Xilio, Aerovate among weekâs notable insider trades